Back
Exelixis Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
54
EXEL
Exelixis
Last Price:
21.95
Seasonality Move:
6.45%
Sell
33
BMY
Bristol-Myers Squibb
Last Price:
44.02
Seasonality Move:
2.19%
Buy
54
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $21.92. The Score for EXEL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.21. The Score for BMY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing slight buying pressure.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 36.55 | Sell |
| Chaikin Money Flow: | 4060293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.72 - 23.74) | Sell |
| Bollinger Bands (100): | (21.58 - 23.66) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.8 | Sell |
| Relative Strength Index (14 RSI): | 24.54 | Sell |
| Chaikin Money Flow: | 3961749 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.26 - 52.12) | Sell |
| Bollinger Bands (100): | (48.46 - 52.52) | Sell |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.28 | Sell |
| 20-day SMA: | 23.12 | Sell |
| 50-day SMA: | 22.88 | Sell |
| 200-day SMA: | 21.92 | Sell |
| 8-day EMA: | 23.08 | Sell |
| 20-day EMA: | 23.12 | Sell |
| 50-day EMA: | 22.89 | Sell |
| 200-day EMA: | 21.79 | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.17 | Sell |
| 20-day SMA: | 48.21 | Sell |
| 50-day SMA: | 50.6 | Sell |
| 200-day SMA: | 53.84 | Sell |
| 8-day EMA: | 45.68 | Sell |
| 20-day EMA: | 47.72 | Sell |
| 50-day EMA: | 49.53 | Sell |
| 200-day EMA: | 54.1 | Sell |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.03 per share, an increase this year of $0.54 per share, and an increase next year of $0.32 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.23 per share, a decrease this year of $6.86 per share, and an increase next year of $6.42 per share.
Exelixis Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||